{"id":"https://openalex.org/W2149068680","doi":"https://doi.org/10.1186/1476-4598-11-42","title":"Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)","display_name":"Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)","publication_year":2012,"publication_date":"2012-06-21","ids":{"openalex":"https://openalex.org/W2149068680","doi":"https://doi.org/10.1186/1476-4598-11-42","mag":"2149068680","pmid":"https://pubmed.ncbi.nlm.nih.gov/22721004","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3489684"},"language":"en","primary_location":{"id":"doi:10.1186/1476-4598-11-42","doi":"https://doi.org/10.1186/1476-4598-11-42","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-4598-11-42","pdf_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-11-42","source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-11-42","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101496466","display_name":"Fei Fei","orcid":"https://orcid.org/0000-0002-0877-5770","observed_orcids":["https://orcid.org/0000-0002-0877-5770"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]},{"id":"https://openalex.org/I4405270452","display_name":"Saban Research Institute","ror":"https://ror.org/00qe7sv26","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405270452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fei Fei","raw_affiliation_strings":["Section of Molecular Carcinogenesis, Division of Hematology/Oncology and The Saban Research Institute of Children's Hospital Los Angeles, Los Angeles, CA 90027, USA","Division of Hematology/Oncology and The Saban Research Institute of Children's Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Molecular Carcinogenesis, Division of Hematology/Oncology and The Saban Research Institute of Children's Hospital Los Angeles, Los Angeles, CA 90027, USA","institution_ids":["https://openalex.org/I1336910626","https://openalex.org/I4405270452"]},{"raw_affiliation_string":"Division of Hematology/Oncology and The Saban Research Institute of Children's Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA","institution_ids":["https://openalex.org/I1336910626","https://openalex.org/I4405270452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027498397","display_name":"Min Lim","orcid":"https://orcid.org/0000-0001-7572-2591","observed_orcids":["https://orcid.org/0000-0001-7572-2591"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]},{"id":"https://openalex.org/I4405270452","display_name":"Saban Research Institute","ror":"https://ror.org/00qe7sv26","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405270452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Lim","raw_affiliation_strings":["Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA","institution_ids":["https://openalex.org/I1336910626","https://openalex.org/I4405270452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008231665","display_name":"Sabine M. Schmidhuber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]},{"id":"https://openalex.org/I4405270452","display_name":"Saban Research Institute","ror":"https://ror.org/00qe7sv26","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405270452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabine Schmidhuber","raw_affiliation_strings":["Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA","institution_ids":["https://openalex.org/I1336910626","https://openalex.org/I4405270452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108500055","display_name":"J\u00fcrgen K. Moll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"J\u00fcrgen Moll","raw_affiliation_strings":["Department of Cell Biology, Nerviano Medical Sciences, Nerviano, MI, I-20014, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell Biology, Nerviano Medical Sciences, Nerviano, MI, I-20014, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060051979","display_name":"John Groffen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]},{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]},{"id":"https://openalex.org/I4405270452","display_name":"Saban Research Institute","ror":"https://ror.org/00qe7sv26","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405270452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Groffen","raw_affiliation_strings":["Departments of Pediatrics and Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA","Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA","Leukemia Research Program, Children\u2019s Hospital Los Angeles, Los Angeles, USA","Leukemia and Lymphoma Program, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pediatrics and Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA","institution_ids":["https://openalex.org/I1336910626","https://openalex.org/I4405270452"]},{"raw_affiliation_string":"Leukemia Research Program, Children\u2019s Hospital Los Angeles, Los Angeles, USA","institution_ids":["https://openalex.org/I1336910626"]},{"raw_affiliation_string":"Leukemia and Lymphoma Program, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077589394","display_name":"Nora Heisterkamp","orcid":"https://orcid.org/0000-0003-2769-2273","observed_orcids":["https://orcid.org/0000-0003-2769-2273"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]},{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]},{"id":"https://openalex.org/I4405270452","display_name":"Saban Research Institute","ror":"https://ror.org/00qe7sv26","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405270452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nora Heisterkamp","raw_affiliation_strings":["Departments of Pediatrics and Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA","Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA","Division of Hematology/Oncology, Ms#54, Children\u2019s Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, USA","Leukemia Research Program, Children\u2019s Hospital Los Angeles, Los Angeles, USA","Leukemia and Lymphoma Program, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pediatrics and Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"Division of Hematology/Oncology and The Saban Research Institute of Children\u2019s Hospital Los Angeles, Section of Molecular Carcinogenesis, Los Angeles, CA, 90027, USA","institution_ids":["https://openalex.org/I1336910626","https://openalex.org/I4405270452"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Ms#54, Children\u2019s Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, USA","institution_ids":["https://openalex.org/I1336910626"]},{"raw_affiliation_string":"Leukemia Research Program, Children\u2019s Hospital Los Angeles, Los Angeles, USA","institution_ids":["https://openalex.org/I1336910626"]},{"raw_affiliation_string":"Leukemia and Lymphoma Program, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5077589394"],"corresponding_institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626","https://openalex.org/I4210117038","https://openalex.org/I4405270452"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":{"value":5090,"currency":"USD","value_usd":5090},"fwci":2.3267,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.88383517,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"1","first_page":"42","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.49540001153945923,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.49540001153945923,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.461899995803833,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.016300000250339508,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/danusertib","display_name":"danusertib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/aurora-kinase-inhibitors","display_name":"Aurora kinase inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pre-b-acute-lymphoblastic-leukemia","display_name":"pre-B acute lymphoblastic leukemia","score":0.9070000052452087},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-leukemia","display_name":"Philadelphia chromosome-positive leukemia","score":0.8560000061988831},{"id":"https://openalex.org/keywords/t315i-mutation","display_name":"T315I mutation","score":0.953000009059906},{"id":"https://openalex.org/keywords/dasatinib-resistance","display_name":"dasatinib resistance","score":0.8199999928474426},{"id":"https://openalex.org/keywords/lonafarnib","display_name":"lonafarnib","score":0.7940000295639038},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.8479999899864197},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.8009999990463257},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.652999997138977},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.628000020980835},{"id":"https://openalex.org/keywords/colony-growth-inhibition","display_name":"colony growth inhibition","score":0.5230000019073486},{"id":"https://openalex.org/keywords/xenograft-survival","display_name":"xenograft survival","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7408707141876221},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.6423163414001465},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5761458873748779},{"id":"https://openalex.org/C20552341","wikidata":"https://www.wikidata.org/wiki/Q4822632","display_name":"Aurora inhibitor","level":4,"score":0.4713315963745117},{"id":"https://openalex.org/C141937037","wikidata":"https://www.wikidata.org/wiki/Q14911664","display_name":"Aurora B kinase","level":5,"score":0.46599307656288147},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4630560576915741},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.43736395239830017},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.4137831926345825},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2993597984313965},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2195470929145813},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.18279892206192017},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.125279039144516},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.11902680993080139},{"id":"https://openalex.org/C85813293","wikidata":"https://www.wikidata.org/wiki/Q188909","display_name":"Cell division","level":3,"score":0.088824063539505},{"id":"https://openalex.org/C47432576","wikidata":"https://www.wikidata.org/wiki/Q918594","display_name":"Spindle apparatus","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015452","descriptor_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015452","descriptor_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015452","descriptor_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064107","descriptor_name":"Aurora Kinase B","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064127","descriptor_name":"Aurora Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/1476-4598-11-42","doi":"https://doi.org/10.1186/1476-4598-11-42","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-4598-11-42","pdf_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-11-42","source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2487991","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3489684","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3489684","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3489684","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Cancer","raw_type":"Text"},{"id":"pmid:22721004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22721004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:29a5264f0ca545469f231684cfd3a9f9","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/29a5264f0ca545469f231684cfd3a9f9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer, Vol 11, Iss 1, p 42 (2012)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1476-4598-11-42","doi":"https://doi.org/10.1186/1476-4598-11-42","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-4598-11-42","pdf_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-11-42","source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G535394260","display_name":"Role of Sialic Acid Modification in ALL Survival and Drug Resistance","funder_award_id":"R01CA090321","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5770352135","display_name":null,"funder_award_id":"CA090321","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2149068680.pdf","grobid_xml":"https://content.openalex.org/works/W2149068680.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W15871531","https://openalex.org/W1556655356","https://openalex.org/W1774775070","https://openalex.org/W1971241832","https://openalex.org/W1980577287","https://openalex.org/W1982209220","https://openalex.org/W1989123817","https://openalex.org/W1992446787","https://openalex.org/W1995563061","https://openalex.org/W2003973314","https://openalex.org/W2004802243","https://openalex.org/W2005499874","https://openalex.org/W2006811655","https://openalex.org/W2007608739","https://openalex.org/W2016462887","https://openalex.org/W2016833582","https://openalex.org/W2025656806","https://openalex.org/W2028959752","https://openalex.org/W2043122200","https://openalex.org/W2050629960","https://openalex.org/W2060286792","https://openalex.org/W2061860992","https://openalex.org/W2065374870","https://openalex.org/W2068057796","https://openalex.org/W2082580993","https://openalex.org/W2086938085","https://openalex.org/W2090004346","https://openalex.org/W2092606584","https://openalex.org/W2093322643","https://openalex.org/W2095745765","https://openalex.org/W2096003848","https://openalex.org/W2096654914","https://openalex.org/W2124196948","https://openalex.org/W2125294721","https://openalex.org/W2128553601","https://openalex.org/W2140557275","https://openalex.org/W2142919712","https://openalex.org/W2142969636","https://openalex.org/W2146472745","https://openalex.org/W2151940004","https://openalex.org/W2152713204","https://openalex.org/W2155451340","https://openalex.org/W2160031924","https://openalex.org/W2162328639","https://openalex.org/W2170542243","https://openalex.org/W2170975933","https://openalex.org/W2171722798","https://openalex.org/W2561307901","https://openalex.org/W2582791630","https://openalex.org/W4239576136"],"related_works":["https://openalex.org/W2561307901","https://openalex.org/W2582791630","https://openalex.org/W2050629960","https://openalex.org/W2563314792","https://openalex.org/W2992554102","https://openalex.org/W2151940004","https://openalex.org/W1814543452","https://openalex.org/W954745799","https://openalex.org/W7095603432","https://openalex.org/W2115667429"],"abstract_inverted_index":{"BACKGROUND:":[0],"Treatment":[1],"of":[2,14,24,73,94,101,109,123,133,172,218,235],"Philadelphia":[3],"chromosome-positive":[4],"acute":[5],"lymphoblastic":[6],"leukemias":[7],"(Ph-positive":[8],"ALL)":[9],"with":[10,119,135,140,143,155,179,206,213,244],"clinically":[11],"approved":[12],"inhibitors":[13],"the":[15,22,29,49,71,96,102,107,136,168,233,253],"Bcr/Abl":[16,50,75,77,193,208],"tyrosine":[17,194],"kinase":[18,43,195,199],"frequently":[19],"results":[20],"in":[21,32,53,63,65,186,201],"emergence":[23],"a":[25,120,156,180,214,245],"leukemic":[26,254],"clone":[27],"carrying":[28],"T315I":[30,51,97,209],"mutation":[31],"Bcr/Abl,":[33,95],"which":[34],"confers":[35],"resistance":[36],"to":[37,47,84,153,251],"these":[38],"drugs.":[39],"PHA-739358,":[40],"an":[41,229],"Aurora":[42,198],"inhibitor,":[44],"was":[45],"reported":[46],"inhibit":[48],"mutant":[52],"CML":[54],"cells":[55,83,211],"but":[56,106],"no":[57],"preclinical":[58],"studies":[59],"have":[60],"examined":[61],"this":[62,85,187],"detail":[64],"human":[66,74,207],"ALL.":[67],"RESULTS:":[68],"We":[69],"compared":[70,152],"sensitivity":[72],"T315I,":[76],"wild":[78],"type":[79],"and":[80,90,142,149,176,197,203,238],"non-Bcr/Abl":[81],"ALL":[82,114,174,210],"drug.":[86,158],"PHA-739358":[87,134,165,189,219,227],"inhibited":[88,127],"proliferation":[89],"induced":[91],"apoptosis":[92],"independently":[93],"mutation,":[98],"or":[99],"presence":[100],"tumor":[103],"suppressor":[104],"p53,":[105],"degree":[108],"effectiveness":[110],"varied":[111],"between":[112],"different":[113],"samples.":[115],"Since":[116],"short-term":[117],"treatment":[118,154,178,234,243],"single":[121,157],"dose":[122],"drug":[124,182,231,247],"only":[125],"transiently":[126],"proliferation,":[128],"we":[129],"tested":[130],"combination":[131],"treatments":[132],"farnesyltransferase":[137],"inhibitor":[138],"Lonafarnib,":[139],"vincristine":[141],"dasatinib.":[144],"All":[145],"combinations":[146],"reduced":[147,167],"viability":[148],"cell":[150],"numbers":[151],"Clonogenic":[159],"assays":[160],"showed":[161],"that":[162],"25":[163],"nM":[164],"significantly":[166,223],"colony":[169,184],"growth":[170,185],"potential":[171],"Ph-positive":[173,237],"cells,":[175],"combined":[177,242],"second":[181,246],"abrogated":[183],"assay.":[188],"further":[190],"effectively":[191],"blocked":[192],"activity":[196],"B":[200],"vivo,":[202],"mice":[204],"transplanted":[205],"treated":[212],"3x":[215],"7-day":[216],"cycle":[217],"as":[220],"mono-treatment":[221],"had":[222],"longer":[224],"survival.":[225],"CONCLUSIONS:":[226],"represents":[228],"alternative":[230],"for":[232],"both":[236],"negative":[239],"ALL,":[240],"although":[241],"may":[248],"be":[249],"needed":[250],"eradicate":[252],"cells.":[255]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}